Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 103-114 , March 2009

Cardiovascular Infection and Inflammation

  • Simona Ben-Haim, MD, DSc

      Affiliations

    • Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Simona Ben-Haim, MD, DSc, Honorary Professor and Consultant Physician, Institute of Nuclear Medicine, University College London Hospitals NHS Trust, 235 Euston Road T5, London NW1 2BU, United Kingdom
    • ,
  • Svetislav Gacinovic, MD, MSc

      Affiliations

    • Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
    • ,
  • Ora Israel, MD

      Affiliations

    • Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
    • The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel

References 

  1. Reyes E, Underwood SR. Nuclear imaging in cardiovascular infection and cardiac transplant rejection. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 981–991
  2. Belhocine T, Blockmans D, Hustinx R, et al. Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? (A critical review of the literature data). Eur J Nucl Med Mol Imaging. 2003;20:1305–1313
  3. Webb M, Al-Nahas A. Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with 18F-FDG PET. Nucl Med Commun. 2006;27:547–549
  4. Amezcua-Guerra LM, Pineda C. Imaging studies in the diagnosis and management of vasculitis. Curr Rheumatol Rep. 2007;9:320–327
  5. Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective endocarditis. Infect Dis Clin North Am. 2002;16:319–337
  6. Jacob S, Tong AT. Role of echocardiography in the diagnosis and management of infective endocarditis. Curr Opin Cardiol. 2002;17:478–485
  7. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol. 2004;32:47–57
  8. Desai SP, Yuille DL. The unsuspected complications of bacterial endocarditis imaged by gallium-67 scanning. J Nucl Med. 1993;34:955–957
  9. Pena FJ, Banzo I, Quirce R, et al. Ga-67 SPECT to detect endocarditis after replacement of an aortic valve. Clin Nucl Med. 2002;27:401–404
  10. Morguet AJ, Dieter M, Ivancevic V, et al. Immunoscintigraphy using technetium-99m-labelled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in sub acute infective endocarditis. J Am Coll Cardiol. 1994;23:1171–1178
  11. Gratz S, Raddaz D, Hagenah G, et al. 99mTc-labelled antigranulocyte monoclonal antibody Fab' fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol. 2000;75:75–84
  12. Erba PA, Lazzeri E, Sollini M, et al. 99mTc-HMPAO WBC SPECT/CT in the evaluation of endocarditis and cardia devices. J Nucl Med. 2008;49(suppl 1):133P;(abstr)
  13. Richardson P, McKenna WJ, Bristow M, et al. Report of the 1995 WHO/ISFC task force on the definition of cardiomyopathies. Circulation. 1996;93:841–842
  14. Calabrese F, van der Wal AC, Levi M. Infection and inflammation in the cardiovascular system. (editorial) Cardiovasc Res. 2003;60:1–4
  15. Connell JB, Henkin RE, Robinson JA, et al. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation. 1984;70:58–62
  16. Mitsutake A, Nakamura M, Inou T, et al. Intense, persistent myocardial avid technetium-99m-pyrophosphate scintigraphy in acute myocarditis. Am Heart J. 1981;101:683–684
  17. Ahmad M, Dubiel JP. Tc-99m pyrophosphate myocardial imaging in perimyocarditis. J Nucl Med. 1981;22:452–454
  18. Yasuda T, Palacios IF, Dec GW, et al. In-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation. 1987;76:306–311
  19. Carrio I, Berna L, Bellester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med. 1988;29:1893–1900
  20. Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol. 1990;16:97–104
  21. Johnston L, Seldin DW, Becker LC, et al. Antimyosin imaging in acute transmural myocardial infarctions: Results of a multicentre clinical trial. J Am Coll Cardiol. 1989;13:27–35
  22. Narula J, Khaw BA, dec GW, et al. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol. 1996;3:371–381
  23. Obrador D, Ballester M, Carrio I, et al. Active myocardial damage without attending inflammatory response in dilated cardiomyopathy. J Am Coll Cardiol. 1993;21:1667–1671
  24. Marti V, Coll P, Ballester M, et al. Enterovirus persistence and myocardial damage detected by 111In-monoclonal antimyosin antibodies in patients with dilated cardiomyopathy. Eur Heart J. 1996;17:545–549
  25. Kodama K, Igase M, Funagda J, et al. Gallium-67 scintigraphy in idiopathic pericarditis—report of a case. Jpn Circ J. 1994;58:298–302
  26. Coupland DB, Terriff B, Fung AY, et al. The “hot halo” sign (Pyogenic pericarditis on In-111 leukocyte scintigraphy). Clin Nucl Med. 1992;17:579–580
  27. Bleeker-Rovers CP, Vos FJ, Wanten GJA, et al. 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med. 2005;46:2014–2019
  28. Seabold JE. Imaging of vascular graft infection. In:  Murray LPC,  Ell PJ editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 2). Edinburgh: Churchill Livingstone; 1999;p. 159–163
  29. Gilbert BR, Cerqueira MD, Vea HW, et al. Indium-111 labelled leukocyte uptake: False-positive results in non-infected pseudo aneurysms. Radiology. 1986;158:761–763
  30. Chung CJ, Wilson AA, Melton JW, et al. Uptake of In-111 labelled leukocytes by lymphocele (A cause of false-positive vascular graft infection). Clin Nucl Med. 1992;17:368–370
  31. Bar-Shalom R, Yefremov N, Guralnik L, et al. SPECT/CT using 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587–594
  32. LaMuraglia GM, Fischman AJ, Strauss HW, et al. Utility of the indium-111-labelled human immunoglobulin G scan for the detection of focal vascular graft infection. J Vasc Surg. 1989;10:20–27
  33. Palestro CJ, Weiland FL, Seabold JE, et al. Localizing infection with a technetium-99m-labelled peptide: initial results. Nucl Med Commun. 2001;22:695–701
  34. Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings. J Vasc Surg. 2005;42:919–925
  35. Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med. 2007;48:120–1236
  36. Ben-Haim S, Seabold JE. Mycotic aneurysms. In:  Murray LPC,  Ell PJ editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 2). Edinburgh: Churchill Livingstone; 1999;p. 165–169
  37. Gonda RL, Gutierrez OH, Azodo MV. Mycotic aneurysms of the aorta: radiologic features. Radiology. 1988;168:343–346
  38. Kaufman JL, Fereshetian A, Chang B, et al. Septicemia presenting with endoaneurysmal gas: CT demonstration. Am J Radiol. 1988;151:287–288
  39. Ben-Haim S, Seabold JE, Hawes DR, et al. Leukocyte scintigraphy in the diagnosis of mycotic aneurysm. J Nucl Med. 1992;33:1486–1493
  40. Cortes J, Alonso JI, Ruis-Olive F, et al. Tc-99m HMPAO-labelled leukocytes in the diagnosis of mycotic aneurysm. Clin Nucl Med. 2002;27:817–818
  41. Meller J, Sahlmann C-O, Scheel AK. 18F-FDG and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45
  42. Bleeker-Rovers CP, Bredie SJH, van der Meer JWM, et al. F-18-Fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Netherlands J Med. 2003;61:323–329
  43. Otsuka H, Morita N, Yamashita K, et al. FDG-PET/CT for diagnosis and follow-up of vasculitis. J Med Invest. 2007;54:345–349
  44. Genereau Y, Lortholary O, Guillevin L, et al. Temporal 67gallium uptake is increased in temporal arteritis. Rheumatology (Oxford). 1999;38:709–713
  45. Reuter H, Wraight EP, Qasim FJ, et al. Management of systemic vasculitis: contribution of scintigraphic imaging to evaluation of disease activity and classification. QJM. 1995;88:509–516
  46. Chen CC, Kerr GS, Carter CS, et al. Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu's arteritis. J Rheumatol. 1995;22:478–481
  47. Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double head coincidence camera (DHCC) and Ga-67 citrate SPECT. Eur J Nucl Med. 2000;27:1617–1625
  48. Kjaer A, Lebech AM, Eigtved A, et al. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG-PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–626
  49. Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum. 2006;55:131–137
  50. Webb M, Chambers A, Al-Nahas A, et al. The role of 18F-FDG PET in characterizing disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627–634
  51. Koyabashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET co-registered with enhanced CT. J Nucl Med. 2005;46:917–922
  52. Meller J, Vosshenrich R, Grabbe E, et al. Value of F-18-FDG-hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol. 2003;13:400–405
  53. Walter MA, Meltzer RA, Schindler C, et al. The value of [18F]FDG in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674–681
  54. Mueller M, Hennes J, Pfannenberg C, et al. Diagnosis of vasculitis with F-18 FDG-PET/CT: Quantification of arterial wall activity in vasculitis patients and controls. J Nucl Med. 2007;48(suppl 2):224P;(abstr)
  55. Both M, Ahmadi-Simab K, Reuter M, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008;67:1030–1033
  56. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford). 1999;38:444–447
  57. Blockmans D, Stroobants S, Maes M, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–249
  58. Belhocine T, Kaye O, Delanaye P, et al. Maladie de Horton et atteintes arterielles extra-temporales: Utilite de la tomography par emission de positons au 18FDG (A propos de trios observations et revue de la literature). Rev Med Interne. 2002;23:1–8
  59. De Winter F, Petrovic M, Van de Viele C, et al. Imaging of giant cell arteritis: Evidence of splenic involvement using FDG positron emission tomography. Clin Nucl Med. 2000;25:633–634
  60. Turlakow A, Yeung HW, Pui J, et al. Fluorodeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001;161:1003–1007
  61. Meller J, Grabbe E, Becker W, et al. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol. 2003;13:400–405
  62. Meller J, Strutz F, Siefker U, et al. early diagnosis and follow up of aortitis with [18F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30:730–736
  63. Davies JR, Rudd JH, Weissberg PL. Molecular and metabolic imaging of atherosclerosis. J Nucl Med. 2004;45:1898–1907
  64. Davies MJ. Stability and instability: Two faces of coronary atherosclerosis—The Paul Dudley White Lecture 1995. Circulation. 1996;94:2013–2020
  65. Davies MJ. Acute coronary thrombosis—the role of plaque disruption and its initiation and prevention. Eur Heart J. 1995;16(suppl L):3–7
  66. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  67. Davies JR, Rudd JF, Fryer TD, et al. Targeting the vulnerable plaque: The evolving role of nuclear imaging. J Nucl Cardiol. 2005;12:234–246
  68. Ben-Haim S, Israel O. PET/CT for atherosclerotic plaque imaging. Q J Nucl Med Mol Imaging. 2006;50:53–60
  69. von Birgelen C, Slager CJ, Di Mario C, et al. Volumetric intracoronary ultrasound: A new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis?. Atherosclerosis. 1995;118(suppl):S103–S113
  70. Nissen SE, Yock P. intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604–616
  71. Mintz GS, Nissen SE, Anderson WD, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478–1492
  72. Ishibashi F, Aziz K, Abela GS, et al. Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J Intervent Cardiol. 2006;19:17–25
  73. Leber AW, Knez A, Becker A, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: A comparative study with intracoronary ultrasound. J Am Coll Cardiol. 2004;43:1241–1247
  74. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: comparative study using intravascular ultrasound. J Am Coll Cardiol. 2006;47:672–677
  75. Sun J, Zhang Z, Lu B, et al. Identification and quantification of coronary atherosclerotic plaques: A comparison of 64-MDCT and intravascular ultrasound. AJR. 2008;190:748–754
  76. Hyafil F, Cornily JC, Feig JE, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007;13:636–641
  77. Tang TY, Howarth SP, Miller SR, et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study. J Neurol Neurosurg Psychiatry. 2007;78:1337–1343
  78. Lees AM, Lees RS, Shoen FJ, et al. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988;8:461–470
  79. Iuliano L, Signore A, Vallabhajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis. 1996;126:131–141
  80. Demacker PNM, Dormans TPJ, Koenders EB, et al. Evaluation of Indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: Effect of age and treatment with antioxidants and ethinylestradiol. J Nucl Med. 1993;34:1316–1321
  81. Sinzinger H, Rodrigues M, Kritz H. Radioisotopic imaging of atheroma. In:  Fuster V editors. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Co, Inc; 1996;p. 369–383
  82. Moriwaki H, Matsumoto M, Handa M, et al. Functional and anatomic evaluation of carotid atherothrombosis (A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography). Arterioscler Thromb Vasc Biol. 1995;15:2234–2240
  83. Knight LC. Scintigraphic methods for detecting vascular thrombosis. J Nucl Med. 1993;3(suppl):554–561
  84. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: A technique with potential for non-invasive imaging of vulnerable plaque. Circulation. 2003;108:3134–3139
  85. Zhao Y, Kuge Y, Zhao S, et al. Changes of lesion accumulation of 99mTc-annexin V and 18F-FDG with the progression of atherosclerosis in apolipoprotein E knockout mice. J Nuc Med. 2005;46(suppl):256P;(abstr)
  86. Bates SM, Lister-James J, Julian JA, et al. Imaging characteristics of a novel technetium Tc99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch Intern Med. 2003;163:452–456
  87. Tawakol A, Migrino RQ, Hoffman U, et al. Noninvasive in-vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294–301
  88. Aziz K, Berger K, Claycombe K, et al. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation. 2008;117:2061–2070
  89. Ogawa M, Magata Y, Kato T, et al. Application of 18F-FDG PET for monitoring the therapeutic effect of anti-inflammatory drugs on stabilization of atherosclerotic plaques. J Nucl Med. 2006;47:1845–1850
  90. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med. 1997;38:1788–1796
  91. Yun M, Yang S, Cucciara A, et al. 18FDG uptake in the large arteries: A correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;37:70–76
  92. Tatsumi M, Cohade C, Nakamoto Y, et al. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: Possible finding for active atherosclerosis. Radiology. 2003;229:831–837
  93. Ben-Haim S, Kupzov E, Tamit A, et al. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med. 2004;45:1816–1821
  94. Bural CG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562–569
  95. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–2711
  96. Davies JR, Rudd JHF, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resonance magnetic-resonance imaging. Stroke. 2005;36:2642–2647
  97. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenustes plaque inflammation (Evaluation by fluorodeoxyglucose positron emission tomography). J Am Coll Cardiol. 2006;48:1825–1831
  98. Ben-Haim S, Kupzov E, Tamir A, et al. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow up PET/CT studies. J Nucl Cardiol. 2006;13:791–800
  99. Dunphy MPS, Freiman A, Larson SM, et al. Association of vascular 18-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278–1284
  100. Rudd JHF, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: Carotid, iliac and femoral uptake reproducibility, quantification methods and recommendations. J Nucl Med. 2008;49:871–878
  101. Rudd JHF, Myers KS, Bansilal S, et al. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible (Implications for atherosclerosis therapy trials). J Am Coll Cardiol. 2007;50:892–896
  102. Tahara N, Kai H, Yamagishi S-I, et al. vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533–1539
  103. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209–217
  104. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid–lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005;46:106–112
  105. Bengel FM. Vascular FDG uptake: Further steps towards clinical acceptance. J Nucl Cardiol. 2008;15:154–156
  106. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. Am J Roentgenol. 2008;190:W151–W156
  107. Matter CM, Wyss MT, Meier P, et al. 18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler Thromb Vasc Biol. 2006;26:584–589
  108. Vallabhajosula S, Granada J, Kothari P, et al. Molecular imaging of vulnerable plaque: Comparison of 3 PET tracers: [11C]PK1195, [18F]Fluorocholine and [18F]FDG in porcine model of complex coronary atherosclerosis (CCA). J Nucl Med. 2007;48(suppl 2):103P;(abstr)
  109. Bucerius J, Schmaljohan J, Boehm I, et al. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans—first results. Eur J Nucl Med Mol Imaging. 2008;35:815–820

PII: S0001-2998(08)00121-9

doi: 10.1053/j.semnuclmed.2008.10.004

Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 103-114 , March 2009

Article Tools

* Image Usage & Resolution